Vanguard Capital Management
MRK icon

Vanguard Capital Management’s Merck MRK Stock Holding History

Vanguard Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7B Buy
161,323,174
+335,550
+0.2% +$39.3M 0.44% 34
2026
Q1 		$19.4B Buy
+160,987,624
New +$18.6B 0.48% 29

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Capital Management's MRK Position: Q2 2026 in Review

Vanguard Capital Management increased its Merck (MRK) stake by 0.21% in Q2 2026, buying an estimated $39.3M and bringing the position to 161,323,174 shares worth $20.7B. The position accounts for 0.44% of the portfolio, ranked #34.

Vanguard Capital Management first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vanguard Capital Management held 161,323,174 shares of Merck worth $20.7B as of Q2 2026.
  • Vanguard Capital Management bought 335,550 Merck shares in Q2 2026, an estimated $39.3M.
  • Merck made up 0.44% of Vanguard Capital Management's portfolio in Q2 2026, its #34 holding.
  • Vanguard Capital Management first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
  • 3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.